Menu

EPIRUS Biopharmaceuticals, Inc. EPRSQ

Full chart Compare
Set alert

Price alert · EPRSQ

All alert types
0.00 0.00

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $900.00KIncome Tax Benefit → Expenses: $544.00KExpenses → Selling, General & Admin: $21.95MExpenses → Research & Development: $30.93MExpenses → Interest Expense: $1.33MGross Profit → Expenses: $576.00KRevenue → Gross Profit: $576.00KRevenue → Cost of Revenue: $125.00KNet Loss → Expenses: $52.19MOther Income$900.00KIncome Tax Benefit$544.00KGross Profit$576.00KNet Loss$52.19MCost of Revenue$125.00KExpenses$54.21MSelling, General & Admin$21.95MResearch & Development$30.93MInterest Expense$1.33MRevenue$701.00K

Latest period ending Dec 31, 2015 · select a line to chart its full history

EPRSQ annual income statement
Fiscal yearFY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011
701.00K4.00K012.55M8.18M
576.00K4.00K012.55M8.18M
-52.30M-39.26M-14.47M-42.84M-42.65M
-52.19M-41.84M-20.80M-44.33M-42.04M
-2.29-6.81-88.26-22.70-25.90
EPRSQ annual balance sheet
Fiscal yearFY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011
33.44M23.29M1.82M4.58M2.80M
72.26M51.38M6.79M61.38M79.88M
35.90M18.98M46.17M30.35M35.97M
14.83M7.27M12.50M15.10M19.13M
36.37M32.40M-39.38M31.03M43.91M
EPRSQ annual cash flow
Fiscal yearFY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011
-46.58M-35.47M-12.88M-38.49M-33.38M
841.00K12.29M-86.00K15.32M-3.62M
55.82M42.84M12.53M24.94M36.94M
-477.00K-1.46M-86.00K260.00K-307.00K
10.05M19.66M-436.00K1.78M-70.00K